Antioxidant resveratrol restores renal sodium transport regulation in SHR

Physiological Reports

Volumn 3, Issue 11, 2015, Pages

  Javkhedkar, Apurva A ^a   Banday, Anees A ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

G proteins; hypertension; Na K ATPase; oxidative stress; transcription factors

Indexed keywords

EID: 84977644419     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12618     Document Type: Article

References (35)

1. Arinze, I. J., and Y. Kawai. 2005. Transcriptional activation of the human Galphai2 gene promoter through nuclear factor-kappaB and antioxidant response elements. J. Biol. Chem. 280:9786–9795.
2. Asghar, M., A. A. Banday, R. Z. Fardoun, and M. F. Lokhandwala. 2006. Hydrogen peroxide causes uncoupling of dopamine D1-like receptors from G proteins via a mechanism involving protein kinase C and G-protein-coupled receptor kinase 2. Free Radic. Biol. Med. 40:13–20.
3. Banday, A. A., and M. F. Lokhandwala. 2008. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling. Hypertension 52:1099–1105.
4. Banday, A. A., and M. F. Lokhandwala. 2011. Angiotensin II-mediated biphasic regulation of proximal tubular Na+/H+ exchanger 3 is impaired during oxidative stress. Am. J. Physiol. Renal. Physiol. 301:F364–F370.
5. Banday, A. A., M. Asghar, T. Hussain, and M. F. Lokhandwala. 2003. Dopamine-mediated inhibition of renal Na, K-ATPase is reduced by insulin. Hypertension 41:1353–1358.
6. Bogdarina, I. G., P. J. King, and A. J. Clark. 2009. Characterization of the angiotensin (AT1b) receptor promoter and its regulation by glucocorticoids. J. Mol. Endocrinol. 43:73–80.
7. Bollang, W. B. 2014. Regulation of aldosterone and secretion. Comp. Physiol. 4:1017–1055.
8. Cheung, B. M., and C. Li. 2012. Diabetes and hypertension: is there a common metabolic pathway? Curr. Atheroscler. Rep. 14:160–166.
9. Copple, I. M. 2012. The keap1-nrf2 cell defense pathway - a promising therapeutic target? Adv. Pharmacol. 63:43–79.
10. Cowling, R. T., D. Gurantz, J. Peng, W. H. Dillmann, and B. H. Greenberg. 2002. Transcription factor NF-kappa B is necessary for up-regulation of type 1 angiotensin II receptor mRNA in rat cardiac fibroblasts treated with tumor necrosis factor-alpha or interleukin-1 beta. J. Biol. Chem. 277:5719–5724.
11. Gildea, J. J., X. Wang, N. Shah, H. Tran, M. Spinosa, R. Van Sciver, et al. 2012. Dopamine and Angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells. Hypertension 60:396–403.
12. Green, T., A. A. Gonzalez, K. D. Mitchell, and L. G. Navar. 2012. The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function. Curr. Opin. Nephrol. Hypertens. 21:7–14.
13. Harris, P. J., and J. A. Young. 1977. Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney. Pflugers Arch. 367:295–297.
14. Hattangady, N. G., L. O. Olala, W. B. Bollag, and W. E. Rainey. 2012. Acute and chronic regulation of aldosterone production. Mol. Cell. Endocrinol. 350:151–162.
15. He, X., L. Wang, G. Szklarz, Y. Bi, and Q. Ma. 2012. Resveratrol inhibits paraquat-induced oxidative stress and fibrogenic response by activating the nuclear factor erythroid 2-related factor 2 pathway. J. Pharmacol. Exp. Ther. 342:81–90.
16. Horiuchi, M., J. Iwanami, and M. Mogi. 2012. Regulation of angiotensin II receptors beyond the classical pathway. Clin. Sci. (Lond.) 123:193–203.
17. Javkhedkar, A. A., M. F. Lokhandwala, and A. A. Banday. 2012. Defective nitric oxide production impairs angiotensin II-induced Na-K-ATPase regulation in spontaneously hypertensive rats. Am. J. Physiol. Renal. Physiol. 302:F47–F51.
18. Kawakami, K., S. Aketa, H. Sakai, Y. Watanabe, H. Nishida, and M. Hirayama. 2011. Antihypertensive and vasorelaxant effects of water-soluble proanthocyanidins from persimmon leaf tea in spontaneously hypertensive rats. Biosci. Biotechnol. Biochem. 75:1435–1439.
19. Khan, S. R. 2012. Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol. Res. 40:95–112.
20. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685.
21. Langford, K., K. Frenzel, B. M. Martin, and K. E. Bernstein. 1992. The genomic organization of the rat AT1 angiotensin receptor. Biochem. Biophys. Res. Commun. 183:1025–1032.
22. Lara, L. S., M. McCormack, L. C. Semprum-Prieto, S. Shenouda, D. S. Majid, H. Kobori, et al. 2012. AT1 receptor-mediated augmentation of angiotensinogen, oxidative stress, and inflammation in ANG II-salt hypertension. Am. J. Physiol. Renal. Physiol. 302:F85–F94.
23. Marwaha, A., A. A. Banday, and M. F. Lokhandwala. 2004. Reduced renal dopamine D1 receptor function in streptozotocin-induced diabetic rats. Am. J. Physiol. Renal. Physiol. 286:F451–F457.
24. Mihara, M., and M. Uchiyama. 1978. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86:271–278.
25. Montezano, A. C., and R. M. Touyz. 2012. Molecular mechanisms of hypertension–reactive oxygen species and antioxidants: a basic science update for the clinician. Can. J. Cardiol. 28:288–295.
26. Ng, C. F., C. M. Koon, D. W. Cheung, M. Y. Lam, P. C. Leung, C. B. Lau, et al. 2011. The anti-hypertensive effect of Danshen (Salvia miltiorrhiza) and Gegen (Pueraria lobata) formula in rats and its underlying mechanisms of vasorelaxation. J. Ethnopharmacol. 137:1366–1372.
27. Nguyen Dinh Cat, A., and R. M. Touyz. 2011. Cell signaling of angiotensin II on vascular tone: novel mechanisms. Curr. Hypertens. Rep. 13:122–128.
28. Pasparakis, M. 2012. Role of NF-kappaB in epithelial biology. Immunol. Rev. 246:346–358.
29. Putnam, K., R. Shoemaker, F. Yiannikouris, and L. A. Cassis. 2012. The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome. Am. J. Physiol. Heart Circ. Physiol. 302:H1219–H1230.
30. Reisman, S. A., G. M. Chertow, S. Hebbar, N. D. Vaziri, K. W. Ward, and C. J. Meyer. 2012. Bardoxolone methyl decreases megalin and activates Nrf2 in the kidney. J. Am. Soc. Nephrol. 23:1663–1673.
31. Ren, J., C. Fan, N. Chen, J. Huang, and Q. Yang. 2011. Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochem. Res. 36:2352–2362.
32. Rieder, S. A., P. Nagarkatti, and M. Nagarkatti. 2012. Multiple anti-inflammatory pathways triggered by resveratrol leading to amelioration of staphylococcal enterotoxin B-induced lung inflammation. Br. J. Pharmacol. 167:1244–1258.
33. Seri, I., B. C. Kone, S. R. Gullans, A. Aperia, B. M. Brenner, and B. J. Ballermann. 1988. Locally formed dopamine inhibits Na+-K+-ATPase activity in rat renal cortical tubule cells. Am. J. Physiol. 255:F666–F673.
34. Shah, S., and T. Hussain. 2006. Enhanced angiotensin II-induced activation of Na+, K+-ATPase in the proximal tubules of obese Zucker rats. Clin. Exp. Hypertens. 28:29–40.
35. Welch, W. J., M. Mendonca, J. Blau, A. Karber, K. Dennehy, K. Patel, et al. 2005. Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat. Kidney Int. 68:179–187.